Literature DB >> 23519088

Management of ventricular tachycardia in heart failure.

Alex Baher1, Miguel Valderrabano.   

Abstract

Ventricular tachyarrhythmias are common in patients with congestive heart failure. The clinical presentation ranges from an asymptomatic incidental electrocardiographic finding to palpitations, syncope, and sudden cardiac death. Although implantable cardioverter defibrillators successfully prevent sudden cardiac death associated with ventricular fibrillation and ventricular tachycardia, recurrent implantable cardioverter defibrillators shocks remain a clinical management challenge. In this review, we discuss management strategies of ventricular tachycardia in congestive heart failure, including drug therapy, radiofrequency catheter ablation (RFCA), and recent RFCA advances.

Entities:  

Keywords:  antiarrhythmic drugs; congestive heart failure; radiofrequency catheter ablation; sudden cardiac death; ventricular tachycardia

Mesh:

Substances:

Year:  2013        PMID: 23519088      PMCID: PMC3600880          DOI: 10.14797/mdcj-9-1-20

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  51 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.

Authors:  Stefan H Hohnloser; Paul Dorian; Robin Roberts; Michael Gent; Carsten W Israel; Eric Fain; Jean Champagne; Stuart J Connolly
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

3.  Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.

Authors:  Marius Volkmer; Feifan Ouyang; Florian Deger; Sabine Ernst; Masahiko Goya; Dietmar Bänsch; Katharina Berodt; Karl-Heinz Kuck; Matthias Antz
Journal:  Europace       Date:  2006-11       Impact factor: 5.214

4.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

5.  Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.

Authors:  Paul Dorian; Martin Borggrefe; Hussein R Al-Khalidi; Stefan H Hohnloser; Jose M Brum; Daljit S Tatla; Johannes Brachmann; Robert J Myerburg; David S Cannom; Michael van der Laan; Michael J Holroyde; Igor Singer; Craig M Pratt
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

6.  Ablation or conservative management of electrical storm due to monomorphic ventricular tachycardia: differences in outcome.

Authors:  Maite Izquierdo; Ricardo Ruiz-Granell; Angel Ferrero; Angel Martínez; Juanmiguel Sánchez-Gomez; Clara Bonanad; Beatriz Mascarell; Salvador Morell; Roberto García-Civera
Journal:  Europace       Date:  2012-06-13       Impact factor: 5.214

7.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.

Authors:  J A Cairns; S J Connolly; R Roberts; M Gent
Journal:  Lancet       Date:  1997-03-08       Impact factor: 79.321

8.  Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.

Authors:  Klaus Kettering; Christian Mewis; Volker Dörnberger; Reinhard Vonthein; Ralph F Bosch; Volker Kühlkamp
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

9.  Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.

Authors:  H C M Kamphuis; J R J de Leeuw; R Derksen; R N W Hauer; J A M Winnubst
Journal:  Europace       Date:  2003-10       Impact factor: 5.214

10.  Arrhythmias in Patients with Heart Failure.

Authors:  B. John Hynes; Jerry C. Luck; Deborah L. Wolbrette; John Boehmer; Gerald V. Naccarelli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12
View more
  2 in total

Review 1.  Substrates and potential therapeutics of ventricular arrhythmias in heart failure.

Authors:  Dongze Zhang; Huiyin Tu; Michael C Wadman; Yu-Long Li
Journal:  Eur J Pharmacol       Date:  2018-06-27       Impact factor: 4.432

2.  Peak Oxygen Uptake on Cardiopulmonary Exercise Test Is a Predictor for Severe Arrhythmic Events during Three-Year Follow-Up in Patients with Complex Congenital Heart Disease.

Authors:  Felix von Sanden; Svetlana Ptushkina; Julia Hock; Celina Fritz; Jürgen Hörer; Gabriele Hessling; Peter Ewert; Alfred Hager; Cordula M Wolf
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.